Moderna Inc. stock underperformed on Friday compared to its competitors

by



[ad_1]

Shares of Moderna Inc. MRNA,
-3.01%
slipped 3.01% to $ 152.52 on Friday, on what turned out to be a favorable trading session for the stock market, with the NASDAQ Composite Index COMP,
+ 0.70%
up 0.70% to 12,464.23 and the Dow Jones Industrial Average DJIA,
+ 0.83%
up 0.83% to 30,218.26. The fall in the stock broke a two-day streak in a row. Moderna Inc. closed $ 25.98 below its 52-week high ($ 178.50), which the company hit on December 1.

The stock underperformed some of its rivals on Friday, such as AbbVie Inc. ABBV,
+ 2.43%
increased 2.43% to $ 107.28, Amgen Inc. AMGN,
+ 1.01%
rose 1.01% to $ 229.21, and AstraZeneca PLC ADR AZN,
+ 1.82%
rose 1.82% to $ 53.74. Trade volume (27.6 M) eclipsed its 50-day average volume of 16.5 Mio.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

[ad_2]

Source link